INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 222 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 1.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $167,000 | -27.4% | 11,090 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $230,000 | -7.3% | 11,090 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $248,000 | -8.1% | 11,090 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $270,000 | -40.9% | 11,090 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $457,000 | -49.9% | 11,090 | -22.1% | 0.00% | -66.7% |
| Q3 2019 | $913,000 | -60.9% | 14,240 | -51.5% | 0.01% | -50.0% |
| Q2 2019 | $2,333,000 | +165.7% | 29,380 | +267.7% | 0.01% | +140.0% |
| Q1 2019 | $878,000 | -35.8% | 7,990 | -45.6% | 0.01% | -44.4% |
| Q4 2018 | $1,367,000 | +55.7% | 14,690 | +83.9% | 0.01% | +80.0% |
| Q3 2018 | $878,000 | +34.3% | 7,990 | -2.4% | 0.01% | +25.0% |
| Q2 2018 | $654,000 | +32.7% | 8,190 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $493,000 | -44.3% | 8,190 | -2.4% | 0.00% | -57.1% |
| Q4 2017 | $885,000 | 0.0% | 8,390 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $885,000 | -14.1% | 8,390 | 0.0% | 0.01% | -12.5% |
| Q2 2017 | $1,030,000 | +8.8% | 8,390 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $947,000 | +222.1% | 8,390 | +223.9% | 0.01% | +200.0% |
| Q4 2016 | $294,000 | -23.2% | 2,590 | +8.4% | 0.00% | -25.0% |
| Q3 2016 | $383,000 | +7.0% | 2,390 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $358,000 | -72.7% | 2,390 | -77.2% | 0.00% | -73.3% |
| Q1 2016 | $1,309,000 | -29.1% | 10,470 | -14.9% | 0.02% | -28.6% |
| Q4 2015 | $1,847,000 | -8.1% | 12,310 | +1.7% | 0.02% | -16.0% |
| Q3 2015 | $2,009,000 | -23.7% | 12,110 | +11.0% | 0.02% | -19.4% |
| Q2 2015 | $2,633,000 | -11.2% | 10,910 | +3.8% | 0.03% | -16.2% |
| Q1 2015 | $2,964,000 | – | 10,510 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |